Synagis Prices, Coupons, Copay Cards & Patient Assistance
Synagis (palivizumab) is a member of the antiviral monoclonal antibodies drug class and is commonly used for RSV, and RSV Vaccination and Immunization.
The cost for Synagis (100 mg/mL) intramuscular solution is around $1,954 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Synagis prices
Intramuscular Solution
100 mg/mL
Synagis intramuscular solution
from $1,953.59
for 0.5 milliliters
| Brand | Quantity | Per unit | Price |
|---|---|---|---|
| Synagis | 1 milliliter | $3,680.04 | $3,680.04 |
| Synagis 50 mg/0.5 mL | 0.5 milliliters | $3,907.18 | $1,953.59 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Synagis Coupons, Copay Cards and Rebates
Synagis offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Synagis Copay Program
Eligible commercially insured patients may pay as little as $0 per dose with a maximum savings of $6,000 per calendar year.
- Applies to:
- Synagis
- Number of uses:
- Per prescription per calendar year
Form more information phone: 833-796-2447 or Visit website
Patient Assistance & Copay Programs for Synagis
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Synagis CONNECT
Eligibility requirements:- Contact program for details.
- Not disclosed
- FDA-approved diagnosis
- Must be a US citizen or permanent resident and treated by a US licensed healthcare provider
- Co-payment assistance, reimbursement support, patient support, and patient assistance programs are available for eligible patients.
- Synagis (palivizumab) Injection
More information please phone: 833-796-2447 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Arexvy
Arexvy is an RSV vaccine used to prevent severe Respiratory Syncytial Virus Vaccine (RSV) symptoms ...
Abrysvo
Abrysvo vaccine protects against LRTD (lower respiratory tract disease) caused by the Respiratory ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Beyfortus
Beyfortus is used to protect babies under 1 year of age from serious RSV lung infections. A ...
mRESVIA
mResvia is an RSV vaccine that may be used to protect adults aged 60 years and older against lower ...
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Rsv vaccine, mrna
Rsv vaccine, mrna systemic is used for RSV, RSV Vaccination and Immunization
More about Synagis (palivizumab)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral monoclonal antibodies
- Breastfeeding
- En español
